Skip to main content

Table 1 Sociodemographic and clinical characteristics

From: Detection of subclinical skin manifestation in patients with psoriasis and psoriatic arthritis by fluorescence optical imaging

  Pso/PsA RA Healthy
n = 80 n = 78 n = 25
Sex, n (%)
 Female 56 70.0 59 75.6 16 64.0
Age in years, mean (SD) 48.5 (12.32) 52.7 (13.23) 29.0 (10.13)
BMI in kg/m2, mean (SD) 27.6 (5.9) 26.1 (4.7)  
Disease duration in years, mean (SD) 8.5 (10.8) 2.4 (4.7)  
Anti-CCP, mean (SD) 12.6 (13.4) 298.8 (401.7)  
 Anti-CCP ≥ 20 U/ml, n (%) 9 11.8 48 63.2   
RF (IgA) in U/ml, mean (SD) 6.9 (7.2) 98.1 (163.0)  
 IGA ≥ 20 U/ml, n (%) 3 3.9 34 44.7   
RF (IgM) in U/ml, mean (SD) 4.2 (4.5) 87.0 (146.1)  
 IGM ≥ 20 U/ml, n (%) 3 3.9 34 44.7   
CRP in mg/l, mean (SD) 3.9 (5.5) 13.2 (16.9)  
ESR in mm/h, mean (SD) 17.2 (11.1) 34.8 (23.3)  
 HLA-B27 positive, n (%) 2 15.4 0 0.0   
 DAS28, mean (SD) (range 0–10) 3.1 (1.4) 5.1 (1.3)  
 TJC-28, mean (SD) (range 0–28) 5.1 (4.5) 8.7 (6.9)  
 SJC-28, mean (SD) (range 0–28) 1.7 (2.4) 5.1 (4.3)  
 Physicians’ global (VAS), mean (SD) (range 0–100) 2.9 (2.0) 4.7 (1.6)  
 PASI, mean (SD) 2.9 (3.2)   
 Body surface area, mean (SD) 8.5 (9.6)   
 Patient’s global (VAS), mean (SD) (range 0–100) 5.0 (2.2) 5.7 (2.1)